Zongertinib gains FDA approval for advanced NSCLC with HER2 mutations, showcasing promising efficacy and safety in clinical ...

Detailed price information for Cardiff Oncology Inc (CRDF-Q) from The Globe and Mail including charting and trades.

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...